|
1
|
Tatemoto K and Mutt V: Isolation and
characterization of two novel candidate hormones using a chemical
method for finding naturally occurring polypeptides. Nature.
285:417–418. 1980. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tatemoto K: Isolation and characterization
of peptide YY (PYY), a candidate gut hormone that inhibits
pancreatic exocrine secretion. Proc Natl Acad Sci USA.
79:2514–2518. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tatemoto K: Neuropeptide Y: the complete
amino acid sequence of the brain peptide. Proc Natl Acad Sci USA.
79:5485–5489. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tatemoto K, Carlquist M and Mutt V:
Neuropeptide Y - a novel brain peptide with structural similarities
to peptide YY and pancreatic polypeptide. Nature. 296:659–660.
1982. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sundler F, Moghimazadeh E, Håkanson R, et
al: Nerve fibers in the gut and pancrease of the rat displaying
neuropeptide Y immunoreactivity. Intrinsic and extrinsic origin.
Cell Tissue Res. 230:487–493. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lundberg JM, Tatemoto K, Terenius L,
Hellerström PM, Mutt V, Hökfelt PM and Hemberger B: Localization of
polypeptide YY (PYY) in gastrointestinal endocrine cells and
effects on intestinal blood flow and motility. Proc Natl Acad Sci
USA. 79:4471–4475. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
El-Salhy M, Grimelius L, Wilander E,
Ryberg B, Lundberg JM, Terenius L and Tatemoto K:
Immunocytochemical identification of polypeptide YY (PYY) cells in
the human gastrointestinal tract. Histochemistry. 77:15–23. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
El-Salhy M: Immunocytochemical
investigation of the gastroentero-pancreatic (GEP) neurohormonal
peptides in the pancrease and gastrointestinal tract of a
cartilaginous fish, the dogfish Squalus achanthias.
Histochemistry. 80:193–205. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
El-Salhy M: The occurrence of polypeptide
YY (PYY) and pancreatic polypeptide (PP) in the gastrointestinal
tract of bony fish. Biomed Res. 5:441–444. 1984.
|
|
10
|
El-Salhy M, Grimelius L, Lundberg JM,
Tatemoto K and Terenius L: Immunocytochemical evidence for the
occurrence of PYY, a newly isolated gut polypeptide, in endocrine
cells in the gut of amphibians and reptiles. Biomed Res. 3:303–306.
1982.
|
|
11
|
El-Salhy M, Wilander E, Abu-Sinna G,
Shabaka H, Abu-Sinna G, Lundberg JM and Tatemoto K: On the ontogeny
of polypeptide YY (PYY) in the chickens. Biomed Res. 3:680–682.
1982.
|
|
12
|
El-Salhy M, Grimelius L, Wilander E,
Lundberg JM, Tatemoto K and Terenius L: The distribution of
polypeptide YY (PYY) and pancreatic polypeptide (PP)-immunoreactive
cells in the domestic fowl. Histochemistry. 75:25–30. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
El-Salhy M, Wilander E, Juntti-Berggren L
and Grimelius L: The distribution and ontogeny of polypeptide YY
(PYY) and polypetide (PP)-immunoreactive cells in the
gastrointestinal tract of rat. Histochemistry. 78:53–60. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
El-Salhy M and Lundqvist M:
Immunocytochemical investigation of polypeptide YY (PYY) and
pancreatic polypeptide (PP) in the gastrointestinal tract of three
rodents. Biomed Res. 5:401–404. 1984.
|
|
15
|
El-Salhy M and Grimelius L:
Immunocytochemical demonstration of polypeptide YY (PYY) in the
gastrointestinal tract of the monkey, Macaca rhesus. Biomed
Res. 4:289–294. 1983.
|
|
16
|
Sandström O and El-Salhy M: Ontogeny and
the effect of aging on pancreatic polypeptide and peptide YY.
Peptides. 23:263–267. 2002.PubMed/NCBI
|
|
17
|
El-Salhy M, Suhr O and Danielsson A:
Peptide YY in gastrointestinal disorders. Peptides. 23:397–402.
2002. View Article : Google Scholar
|
|
18
|
Ballantyne GH: Peptide YY (1–36) and
peptide YY (3–36): Part I. Distribution, release and actions. Obes
Surg. 16:651–658. 2006.
|
|
19
|
Grudell ABM and Camilleri M: The role of
peptide YY in integrative gut physiology and potent role in
obesity. Curr Opin Endocrinol Diabetes Obes. 14:52–57. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Batterham RL, Crowley MA, Small CJ, Herzog
H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone
RD and Bloom SR: Gut hormone PYY (3–36) physiologically inhibits
food intake. Nature. 418:650–654. 2002.
|
|
21
|
Broberger C: Brain regulation of food
intake and appetite: molecules and networks. J Intern Med.
258:301–327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McGowan BM and Bloom SR: Peptide YY and
appetite control. Curr Opin Pharmacol. 4:583–588. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mannon P and Taylor I: The pancreatic
polypeptide family. Gut Peptides: Biochemistry and Physiology.
Walsh B and Dockary G: Raven Press; New York: pp. 351–358. 1994
|
|
24
|
Spiller RC, Trotman IF, Higgins BE, Ghati
MI, Grimble GK, Lee YC, Bloom SR, Misiewicz JJ and Silk DBA: The
ileal brake-inhibition of jujunal motility after ileal fat
perfusion in man. Gut. 25:365–374. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Spiller RC, Trotma IF, Adrian TE, Bloom
SR, Misiewicz JJ and Silk DB: Further characterisation of the
‘ileal brake’ reflex in man-effect of ileal infusion of partial
digests of fat, protein, and starch on jejunal motility and release
of neurotensin, enteroglucagon, and peptride YY. Gut. 29:1042–1051.
1988.
|
|
26
|
El-Salhy M, Gundersen D, Hatlebakk JG and
Hausken T: Diagnosis, Pathogenesis and Treatment Options. Nova
Science Publishers; New York: 2012
|
|
27
|
El-Salhy M, Gundersen D, Østgaard H,
Lomholt-Beck B, Hatlebakk JG and Hausken T: Low densities of
serotonin and peptide YY cells in the colon of patients with
irritable bowel syndrome. Dig Dis Sci. 57:873–878. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Coates MD, Mahoney CR, Linden DR, Sampson
JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Greshon MD, Mawe GM
and Moses PL: Molecular defects in mucosal serotonin content and
decreased serotonin reuptake transporter in ulcerative colitis and
irritable bowel syndrome. Gastroenterology. 126:1657–1664. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
El-Salhy M, Vaali K, Dizdar V and Hausken
T: Abnormal small-intestinal endocrine cells in patients with
irritable bowel syndrome. Dig Dig Sci. 55:3508–3513. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Blackshaw LA and Grundy D: Effects of
5-hydroxytryptamine on discharge of vagal mucosal afferent fibres
from the upper gastrointestinal tract of the ferret. J Auton Nerv
Syst. 45:41–50. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kirchgessner AL, Tamir H and Gershon MD:
Identification and stimulation by serotonin of intrinsic sensory
neurons of the submucosal plexus of the guinea pig gut:
activity-induced expression of Fos immunoreactivity. J Neurosci.
12:235–249. 1992.PubMed/NCBI
|
|
32
|
Kirchgessner AL, Liu MT and Gershon MD: In
situ identification and visualization of neurons that mediate
enteric and enteropancreatic reflexes. J Comp Neurol. 371:270–286.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hillsley K and Grundy D: Sensitivity to
5-hydroxytryptamine in different afferent subpopulations within
mesenteric nerves supplying the rat jejunum. J Physiol.
509:717–727. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grundy D, Blackshaw LA and Hillsley K:
Role of 5-hydroxytryptamine in gastrointestinal chemosensitivity.
Dig Dis Sci. 3(Suppl 12): S44–S47. 1994. View Article : Google Scholar
|
|
35
|
Pan H and Gershon MD: Activation of
intrinsic afferent pathways in submucosal ganglia of the guinea pig
small intestine. J Neurosci. 20:3295–3309. 2000.PubMed/NCBI
|
|
36
|
Sidhu M and Cooke HJ: Role for 5-HT and
ACh in submucosal reflexes mediating colonic secretion. Am J
Physiol. 269:G346–G351. 1995.PubMed/NCBI
|
|
37
|
Cooke HJ, Sidhu M and Wang YZ: 5-HT
activates neural reflexes regulating secretion in the guinea-pig
colon. Neurogastroenterol Motil. 9:181–186. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim M, Cooke HJ, Javed NH, Carey HV,
Christofi F and Raybould HE: D-glucose releases 5-hydroxytryptamine
from human BON cells as a model of enterochromaffin cells.
Gastroenterology. 121:1400–1406. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gershon MD: Review article: serotonin
receptors and transporters-roles in normal and abnormal
gastrointestinal motility. Aliment Pharmacol Ther. 20(Suppl 7):
S3–S14. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bearcroft CP, Andre EA and Farthing MJ: In
vivo effects of the 5-HT3 antagonist alosetron on basal and
cholerat toxin-induced secretion in the human jejunum: a segmental
perfusion study. Aliment Pharmacol Ther. 11:1109–1114. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Camilleri M: Is there a SERT-ain
association with IBS. Gut. 53:1396–1398. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yeo A, Boyd P, Lumsden S, Saunders T,
Handley A, Stubbins M, Knaggs A, Asquith S, Taylor I, Bahari B,
Crocker N, Rallan R, Varsani S, Montgomery D, Alpers DH, Dukes GE,
Purvis I and Hicks GA: Association between a functional
polymorphism in the serotonin transporter gene and diarrhea
predominant irritable bowel syndrome in women. Gut. 53:1452–1458.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li Y, Nie Y, Xie J, Tang W, Liang P, Sha
W, Yang H and Zhou Y: The association of serotonin transporter
genetic polymorphisms and irritable bowel syndrome and its
influence on tegaserod treatment in Chinese patients. Dig Dis Sci.
52:2942–2949. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Park SY, Rew JS, Lee SM, Ki HS, Lee KR,
Cheo JH, Kim HI, Noh DY, Joo YE, Kim HS and Choi SK: Association of
CCK(1) receptor gene polymorphisms and irritable bowel syndrome in
Korean. J Neurogastroenterol Motil. 16:71–76. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang LH, Fang XC and Pan GZ: Bacillary
dysentery as a causative factor for irritable bowel syndrome and
its pathogenesis. Gut. 53:1096–1101. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Spiller RC, Jenkins D, Thornely JP, Hebden
JM, Wright T, Skinner M and Neal KR: Increased rectal mucosal
enteroendocrine cells, T lymphocytes, and increased gut
permeability following acute Campylobacter enteritis and in
post-dysenteric irritable bowel syndrome. Gut. 47:804–811. 2000.
View Article : Google Scholar
|
|
47
|
Dunlop SP, Jenkins D, Neal KR and Spiller
RC: Relative importance of enterochromaffin cell hyperplasia,
anxiety, and depression in postinfectious IBS. Gastroenterology.
125:1651–1659. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lee KJ, Kim YB, Kwon HC, Kim DK and Cho
SW: The alteration of enterochromaffin cell, mast cell and lamina
propria T lymphocyte numbers in irritable bowel syndrome and its
relationship with psychological factors. J Gastroenterol Hepatol.
3:1689–1694. 2008.PubMed/NCBI
|
|
49
|
Kim HS, Lim JH, Park H and Lee SI:
Increased immunoreactive cells in intestinal mucosa of
postinfectious irritable bowel syndrome patients 3 years after
acute Shigella infection - an observation in a small case control
study. Yonsei Med. 51:45–51. 2009.
|
|
50
|
Dizdar V, Spiller R, Hanevik K, Gilja OH,
El-Salhy M and Hausken T: Relative importance of abnormalities of
CCK and 5-HT (serotonin) in Giardia-induced post-infectious
irritable bowel syndrome and functional dyspepsia. Aliment
Pharmacol Ther. 31:883–891. 2010.PubMed/NCBI
|
|
51
|
Liszka L, Woszczyk D and Pajak J:
Histopathological diagnosis of microscopic colitis. J Gastroenterol
Hepatol. 21:792–797. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
El-Salhy M, Danielsson A, Stenling R and
Grimelius L: Colonic endocrine cells in inflammatory bowel disease.
J Intern Med. 242:413–419. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Böttcher G, Alumets J, Håkanson R and
Sundler F: Co-existence of glicentin and peptide YY in colorectal
L-cells in cat and man. An electron microscopic study. Regul Pept.
13:283–291. 1986.PubMed/NCBI
|
|
54
|
Ali-Rachedi A, Varndell MI, Adrian TE,
Gapp DA, van Noorden S, Bloom SR and Polak JM: Peptide YY (PYY)
immunoreactivity is co-stored with glucagon-related immunoreactants
in endocrine cells of the gut and pancreas. Histochemistry.
80:487–491. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Nilsson O, Bilchik AJ, Goldenring JR,
Ballantyne GH, Adrian TE and Modlin IM: Distribution and
immunocytochemical colocalization of peptide YY and enteroglucagon
in endocrine cells of the rabbit colon. Endocrinology. 129:139–148.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lu SJ, Liu YQ, Lin JS, Wu HJ, Sun YH and
Tan YB: VIP immunoreactive nerve and somatostatin and serotonin
containing cells in Crohn’s disease. World J Gastroenterol.
5:541–543. 1999.PubMed/NCBI
|
|
57
|
Stoyanova II and Gulubova MV: Mast cells
and inflammatory mediators in chronic ulcerative colitis. Acta
Histochem. 104:185–192. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
El-Salhy M, Gundersen D, Hatlebakk JG and
Hausken T: High densities of serotonin and peptide YY cells in the
colon of patients with lymphocytic colitis. World J Gastroenterol.
18:6070–6075. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Qian BF, El-Salhy M, Melgar S, Hammarström
ML and Danielsson A: Neuroendocrine changes in colon of mice with a
disrupted IL-2 gene. Clin Exp Immunol. 120:424–433. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Hirotani Y, Mikajiri K, Ikeda K, Myotoku M
and Kurokawa N: Changes in the peptide YY levels in the intestinal
tissue of rats with experimental colitis following oral
administration of mesalazine and prednisolone. Yakugaku Zasshi.
128:1347–1353. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Spiller R: Serotonin, inflammation, and
IBS: fitting the jigsaw together? J Pediatr Gastroenterol Nutr.
45(Suppl 2): S115–S119. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Khan WI and Ghia JE: Gut hormones:
emerging role in immune activation and inflammation. Clin Exp
Immunol. 161:19–27. 2010.PubMed/NCBI
|
|
63
|
Yang GB and Lackner AA: Proximity between
5HT secreting enteroendocrine cells and lymphocytes in gut mucosa
of rhesus macaques (Macaca mulatta) is suggestive of a role
for enterochromaffin cell 5HT in mucosal immunity. J Neuroimmunol.
146:46–49. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
MacDonald A, Baxter JN and Finlay IG:
Idiopathic slow-transit constipation. Br J Surg. 80:1107–1111.
1993. View Article : Google Scholar
|
|
65
|
El-Salhy M: Chronic idiopathic slow
transit constipation: pathophysiology and management. Colorectal
Dis. 5:288–296. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Bassotti G, Gaburri M, Imbimbo BP, Rossi
L, Faroni F, Pelli MA and Morelli A: Colonic mass movement in
idiopathic chronic constipation. Gut. 29:1173–1178. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Bassotti G, Betti C, Pelli MA and Morelli
A: Prolonged (24-hour) manometeric recording of rectal contractile
activity in patients with slow transit constipation. Digestion.
49:72–77. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Bassotti G, Chiarioni G, Imbimbo BP, Betti
C, Bonfante F, Vantini I, Morelli A and Whitehead WE: Impaired
colonic motor response to cholinergic stimulation in patients with
severe chronic idiopathic (slow transit type) constipation. Dig Dis
Sci. 38:1040–1045. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Bazocchi IG, Ellis J, Meyer J, Mena I,
Reddy SN and Morento-Osset E: Colonic scintigraphy and manometry in
constipation, diarrhea and inflammatory bowel disease.
Gastroenterology. 94:A291988.
|
|
70
|
Klauser AG, Peyerl C, Schindbeck NE and
Müller-Lissner SA: Nutrition and physical activity in chronic
constipation. Eur J Gastroenterol Hepatol. 4:227–233. 1992.
|
|
71
|
Sjölund K, Fasth S, Ekman R, Hulten L,
Jiborn H, Nordgren S and Sundler F: Neuropeptides in idiopathic
chronic (slow transit constipation). Neurogastroenterol Motil.
9:143–150. 1997.
|
|
72
|
El-Salhy M, Norrgård Ö and Spinnell S:
Abnormal colonic endocrine cells in patients with chronic
idiopathic slow-transit constipation. Scand J Gastroenterol.
34:1007–1011. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
El-Salhy M and Norrgård Ö: Colonic
neuroendocrine peptide levels in patients with chronic idiopathic
slow transit constipation. Ups J Med Sci. 103:223–230. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Tough IR and Cox HM: Selective inhibition
of neuropeptide Y Y1, receptors by B1BP3226 in rat and human
epithelial preparations. Eur J Pharmacol. 310:55–60. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
75
|
El-Salhy M: The nature and implication of
intestina1 endocrine cell changes in coeliac disease. Histol
Histopathol. 13:1069–1075. 1998.PubMed/NCBI
|
|
76
|
Adrian TE, Savage AP, Bacarese-Hamilton
AJ, Wolfe K, Besterman HS and Bloom SR: Peptide YY abnormalities in
gastrointestinal diseases. Gastroenterology. 90:379–384.
1986.PubMed/NCBI
|
|
77
|
Sjölund K and Ekman R: Increased plasma
level of peptide YY in coeliac disease. Scand J Gastroenterol.
23:297–300. 1988.PubMed/NCBI
|
|
78
|
Adrian TE, Thompson JS and Quigley EM:
Time course of adaptive regulatory peptide changes following
massive small bowel resection in the dog. Dig Dis Sci.
41:1194–1203. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Enck P, Rathmann W, Spiekermann M, Czener
D, Tschöpe D, Ziegler D, Strohmeyer G and Gries FA: Prevalence of
gastrointestinal symptoms in diabetic patients and non-diabetic
subjects. Z Gastroenterol. 32:637–641. 1996.PubMed/NCBI
|
|
80
|
Feldman M and Schiller LR: Disorders of
gastrointestina1 motility associated with diabetes mellitus. Ann
Intern Med. 98:378–384. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Locke GR III: Epidemiology of
gastrointestinal complications of diabetes mellitus. Eur J
Gastroenterol Hepatol. 7:711–716. 1995.PubMed/NCBI
|
|
82
|
Schwartz E, Palmér M, Ingberg CM, Åman J
and Berne C: Increased prevalence of gastrointestinal symptoms in
long-term type 1 diabetes mellitus. Diabet Med. 13:478–781. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
83
|
El-Salhy M: The possible role of the gut
neuroendocrine system in diabetes gastroenteropathy. Histol
Histopathol. 17:1153–1161. 2002.PubMed/NCBI
|
|
84
|
El-Salhy M: Overview of diabetic
gastroenteropathy. Geriatric Times. 4:15–16. 2003.
|
|
85
|
El-Salhy M: Gut neuroendocrine system in
diabetes gastroenteropathy: possible role in pathophysiology and
clinical implications. Focus on Diabetes Research. Ashley M: Nova
Science Publishers; New York: pp. 79–102. 2006
|
|
86
|
El-Salhy M and Sitohy B: Abnormal
gastrointestinal endocrine cells in patients with diabetes type 1:
relationship to gastric emptying and myoelectrical activity. Scand
J Gastroenterol. 36:1162–1169. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
El-Salhy M: Neuroendocrine peptides in
stomach and colon of an animal model for human diabetes type 1. J
Diabetes Complications. 13:170–173. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
El-Salhy M: Gastrointestinal transit in
non-obese diabetic mouse: an animal model of human diabetes type l.
J Diabetes Complications. 15:277–284. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
El-Salhy M: Gastric emptying in an animal
model of human diabetes type 1: relation to endocrine cells. Acta
Diabetol. 38:139–144. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
El-Salhy M: Neuroendocrine peptides of the
gastrointestinal tract of an animal model of human type 2 diabetes
mellitus. Acta Diabetol. 35:194–198. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Portela-Gomes GM, Wilander E, Grimelius L,
Bergström R and Ruhn G: The enterochromaffin cells in the mouse
gastrointestinal tract after streptozotocin treatment. Pathol Res
Pract. 186:260–264. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Sitohy B and El-Salhy M: Colonic endocrine
cells in rats with chemically induced colon carcinoma. Histol
Histopathol. 16:833–838. 2001.PubMed/NCBI
|
|
93
|
El-Salhy M and Wilander E: Colonic
neuroendocrine peptides in rats with chemically-induced colon
carcinoma. GI Cancer. 3:73–78. 1999.
|
|
94
|
El-Salhy M, Norrgård O and Boström A: Low
levels of colonic somatostatin and galanin in patients with colon
carcinoma. GI Cancer. 2:221–225. 1998.
|
|
95
|
El-Salhy M, Mahdavi J and Norrgård Ö:
Colonic endocrine cells in patients with carcinoma of the colon.
Eur J Gastroenterol Hepatol. 10:517–522. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
El-Salhy M, Norrgård Ö, Franzén L and
Forsgren S: Colonic endocrine cells in patients with carcinoma of
the rectum with special regard to preoperative irradiation. GI
Cancer. 2:285–292. 1998.
|
|
97
|
Baldwin GS and Whitehead RH: Gut hormones,
growth and malignancy. Baillieres Clin Endocrinol Metab. 8:185–214.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Björk J, Nilsson R, Hultcranz R and
Johansson C: Growth regulatory effects of sensory neuropeptides,
epidermal growth factor, insulin, and somatostatin on
non-transformed intestinal epithelial cell line IEC-6, and colon
cancer cell line HT 29. Scand J Gastroenterol. 28:879–884.
1993.
|
|
99
|
El-Salhy M: Triple treatment with
octreotide, galanin and serotonin is a promising therapy for
colorectal cancer. Curr Pharma Des. 11:2107–2117. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Anan I: The neuroendocrine system in
patients with familial amyloidotic polyneuropathy. (unpublished PhD
thesis) Umeå University Medical Dissertations. 2000
|
|
101
|
Anan I, El-Salhy M, Ando Y, Nyhlin N,
Terazaki H, Sakashita N and Suhr O: Colonic endocrine cells in
patients with familial amyloidotic polyneuropathy. J Intern Med.
245:469–473. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
El-Salhy M and Suhr O: Enocrine cells in
rectal biopsy specimens from patients with familial amyloidotic
polyneuropathy. Scand J Gastroenterol. 31:68–73. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Rönnblom A, Danielsson Å and EI-Salhy M:
Intestinal endocrine cells in myotonic dystrophy: an
immunohistochemical and computed image ana1ytical study. J Intern
Med. 245:91–97. 1999.
|
|
104
|
Andersson R: Familial amyloidosis with
polyneuropathy. A clinical study based on patients living in
northern Sweden. Acta Med Scand Suppl. 590:1–64. 1976.PubMed/NCBI
|
|
105
|
Steen L and Ek B: Familial amyloidosis
with polyneuropathy. A long term follow-up of 21 patients with
reference to gastrointestinal symptoms. Acta Med Scand.
214:387–397. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Suhr O, Danielsson Å and Steen L: Bile
acid malabsorption caused by gastrointestinal motility dysfunction?
An investigation of gastrointestinal disturbances in familial
amyloidosis with polyneuropathy. Scand J Gastroenterol. 27:201–207.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Akesson A and Ekman R: Gastrointestinal
regulatory peptides in systemic sclerosis. Arthritis Rheum.
36:698–703. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Yamashita Y, Toge T and Adrian TH:
Gastrointestinal hormone in dumping syndrome and reflux esophigitis
after gastric surgery. J Smooth Muscle Res. 33:37–48. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Andrews NJ and Irving MH: Human gut
hormone profiles in patients with short bowel syndrome. Dig Dis
Sci. 37:729–732. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Pietroletti R, Slores FJ, Mariani P, Leard
IS, Simi M and Brummelkamp WH: Enteroglucagon and peptide YY
response after construction of pelvic reservoir in humans. Dis
Colon Rectum. 33:966–969. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Soper NJ, Chapman NJ, Kelly K, Brown ML,
Phillips SF and Go VL: The ‘ileal brake’ after ileal pouch-anal
anastomosis. Gastroenterology. 98:111–116. 1990.
|
|
112
|
Healey KL, Bines JE, Thomas SL, Wilson G,
Taylor RG, Sourial M and Pereira-Fantini PM: Morphological and
functional changes in the colon after massive small bowel
resection. J Pediatr Surg. 45:1581–1590. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Liu CD, Aloia T, Adrian TE, Newton TR,
Bilchik AJ, Zinner MJ, Ashley SW and McFadden DW: Peptide YY: a
potential proabsorptive hormone for the treatment of malabsorption
disorders. Am Surg. 62:232–236. 1996.PubMed/NCBI
|
|
114
|
Liu CD, Hines OJ, Whang EE,
Balasubramanian A, Newton TR, Zinner MJ, Ashley SW and McFadden DW:
A novel synthetic analog of peptide YY, BIM-43004, given
intraluminally, is proabsorptive. J Surg Res. 59:80–84. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Degen L, Oesch S, Casanova M, Graf S,
Ketterer S, Drewe J and Beglinger C: Effect of peptide YY3-36 on
food intake in humans. Gastroenterology. 129:1430–1436. 2005.
View Article : Google Scholar : PubMed/NCBI
|
